Janney Montgomery Scott LLC Inovio Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$1.44 - $3.98 $2,160 - $5,970	-1,500 Reduced 8.7%	15,740 $29,000
Q4 2021 Jan 27, 2022	SELL	$4.99 - $7.46 $998 - $1,492	-200 Reduced 1.15%	17,240 $86,000
Q3 2021 Oct 29, 2021	BUY	$7.16 - $9.69 $7,160 - $9,690	1,000 Added 6.08%	17,440 $125,000
Q2 2021 Jul 26, 2021	SELL	$6.23 - $10.03 $6,230 - $10,030	-1,000 Reduced 5.73%	16,440 $152,000
Q1 2021 Apr 27, 2021	BUY	$8.81 - $16.96 $4,757 - $9,158	540 Added 3.2%	17,440 $162,000
Q4 2020 Jan 25, 2021	BUY	$8.5 - $12.85 $1,360 - $2,056	160 Added 0.96%	16,900 $150,000
Q3 2020 Nov 06, 2020	SELL	$9.57 - $27.05 $3,493 - $9,873	-365 Reduced 2.13%	16,740 $194,000
Q2 2020 Jul 23, 2020	BUY	$7.14 - $31.69 $122,129 - $542,057	17,105 New	17,105 $461,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.